We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
-5.26%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$4.99B
AUM Growth
-$891M
Cap. Flow
-$318M
Cap. Flow %
-6.36%
Top 10 Hldgs %
65.18%
Holding
54
New
3
Increased
9
Reduced
10
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 40.99%
2 Materials 11.51%
3 Communication Services 5.56%
4 Technology 3.99%
5 Financials 3.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$129B
$600M 12.01%
4,320,022
AGN
2
DELISTED
Allergan plc
AGN
$493M 9.88%
2,932,170
+682,670
+30% +$111M
BHC icon
3
Bausch Health
BHC
$1.75B
$455M 9.12%
20,839,035
CELG
4
DELISTED
Celgene Corp
CELG
$317M 6.35%
3,194,678
-155,322
-5% -$14.8M
DISCK
5
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$269M 5.39%
10,922,500
VTRS icon
6
Viatris
VTRS
$19.8B
$237M 4.76%
12,005,400
+1,000,000
+9% +$19.6M
AU icon
7
AngloGold Ashanti
AU
$37.9B
$234M 4.68%
12,782,400
TAK icon
8
Takeda Pharmaceutical
TAK
$54.4B
$228M 4.56%
13,244,711
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$222M 4.46%
8,170,700
+1,500,000
+22% +$38.8M
AAMI
10
Acadian Asset Management
AAMI
$2.93B
$198M 3.97%
20,000,552
DISH
11
DELISTED
DISH Network Corp.
DISH
$169M 3.39%
4,973,500
AABA
12
DELISTED
Altaba Inc
AABA
$148M 2.97%
7,605,722
+5,705,559
+300% +$377M
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
$145M 2.91%
561,397
-26,303
-4% -$7.26M
ONCE
14
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$139M 2.79%
1,437,666
+679,859
+90% +$68.1M
NG icon
15
NovaGold Resources
NG
$2.29B
$133M 2.67%
21,992,896
TSLA icon
16
PUT
Tesla
TSLA
$1.39T
$120M 2.41%
7,500,000
-547,500
-7% -$8.57M
BID
17
DELISTED
Sotheby's
BID
$106M 2.11%
1,853,157
-1,514,643
-45% -$87.7M
CPE
18
DELISTED
Callon Petroleum Company
CPE
$93.7M 1.88%
+2,159,352
New +$105M
S
19
DELISTED
Sprint Corporation
S
$77.7M 1.56%
12,585,700
+4,585,700
+57% +$31.6M
PCRX icon
20
Pacira BioSciences
PCRX
$997M
$65.4M 1.31%
1,716,727
+757,730
+79% +$30.2M
TIMB icon
21
TIM SA
TIMB
$10.6B
$53.4M 1.07%
3,720,000
-1,280,000
-26% -$19.3M
VSM
22
DELISTED
Versum Materials, Inc.
VSM
$52.9M 1.06%
1,000,000
VIAB
23
DELISTED
Viacom Inc. Class B
VIAB
$51.7M 1.03%
2,150,000
+827,000
+63% +$23.1M
PSDO
24
DELISTED
Presidio, Inc. Common Stock
PSDO
$44.8M 0.9%
+2,650,000
New +$39.5M
B
25
Barrick Mining
B
$58.5B
$35.3M 0.71%
2,036,752
+4,095
+0.2% +$72.3K

Similar funds

Paulson & Co's Q3 2019 Portfolio in Review

As of Q3 2019, Paulson & Co held 54 positions worth $4.99B, down 15% from $5.88B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Paulson & Co withdrew a net $318M in Q3 2019, closing 9 positions and reducing 10 holdings. Its most notable exit was Anadarko Petroleum, an estimated $305M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 35% a quarter earlier, followed by Materials and Communication Services.

Against the trend, Paulson & Co opened a new position in Callon Petroleum Company worth $93.7M.

  • Paulson & Co's largest Q3 2019 buy was Callon Petroleum Company: 2,159,352 shares worth $93.7M.
  • Paulson & Co added most to Altaba Inc in Q3 2019, an estimated $377M increase.
  • Paulson & Co's biggest Q3 2019 reduction was T-Mobile US, cutting an estimated $150M.
  • Paulson & Co fully exited Anadarko Petroleum in Q3 2019, selling an estimated $305M.
  • Paulson & Co's ten largest holdings make up 65% of its $4.99B portfolio in Q3 2019.
  • Paulson & Co opened 3 new positions and closed 9 in Q3 2019.
  • Paulson & Co's portfolio value fell 15% quarter-over-quarter to $4.99B.

Based on Paulson & Co's 13F filing for Q3 2019, filed 14 Nov 2019.